Clinipace experts will exhibit at the American Society of Clinical Oncology Annual Meeting June 3-7 in Chicago. We’ll be at booth #2122—stop by and say hello if you’d like to learn more about our experience with global oncology clinical trials and how we use technology to help our clients succeed.
The Annual Meeting brings together 30,000 oncology professionals from around the world to attend educational sessions featuring world-renowned faculty discussing state-of-the-art treatment modalities, new therapies and ongoing controversies in the field. Additionally, science sessions will present the latest groundbreaking research in oral and poster format.
The following Clinipace experts will be in attendance:
Barb Geiger, BSN, RN
Executive Vice President, Clinical Operations
Barb has more than 25 years of experience in the conduct and management of Phase I-IV clinical trials and in the evaluation and selection of global clinical trial vendors. Prior to founding Worldwide Clinical Research (WWCR) in 2000, she spent 10 years at global CROs. Additionally, Barb spent eight years at a major pharmaceutical company and started her clinical research career in a Phase I/II private research unit.
Peter Langecker, MD, PhD
Executive Medical Director, Global Oncology
Peter has more than 25 years of extensive hands-on experience in establishing and conducting industry-sponsored oncology and hematology clinical research and development according to GCP, GLP and GMP regulations. His primary responsibilities at Clinipace Worldwide include the provision of internal and external drug development, regulatory strategy and medical affairs consulting to Clinipace project teams and clients. Peter’s medical training and published research is focused on preclinical and clinical oncology and the hormonal regulation of breast cancer. He is an author and co-author of more than 50 publications and posters.
Ofelia Rodriguez Nievas, MD
Senior Director of Operations, Latin America
Ofelia is a board-certified medical oncologist based in Buenos Aires, Argentina. After spending 20 years as a practitioner and clinical investigator, she started working in the CRO industry. Over the past 15 years, Ofelia has performed medical affairs activities as a medical monitor and safety physician as well as operational tasks for clinical trials in the region. In her role at Clinipace, which she has held for the past 10 years, she is responsible for overseeing the management of the Latin America office. She is also responsible for business development, operational and medical monitoring activities.
Senior Project Manager
Daniela is a pharmacist who has her MBA in project management. She has more than 14 years of experience in the clinical research industry and eight years of experience as a project manager. Daniela has extensive experience with Phase I to IV clinical trials from startup to closeout. She has significant experience in oncology (lung, pancreas and prostate), among several other therapeutic areas.
Pablo is a biochemist with extensive oncology experience. He has been in the clinical research industry for more than 15 years. As a clinical operations professional, he has managed Phase I to Phase IV local (Argentina), regional (Latin America) and global clinical trials.
Senior Director, Project Management
Darcy has more than 18 years of pharmaceutical experience in global project management and clinical operations working on both the pharmaceutical and CRO sides. Her therapeutic experience is in oncology (solid tumor and hematology), neuroscience (multiple sclerosis, ADHD, smoking cessation, Alzheimer’s disease, Parkinson’s disease, pain, schizophrenia and depression), women’s health (contraception, pre-term birth and hormone replacement therapy), infectious disease (bacteremia) and clinical pharmacology studies in multiple therapeutic areas. She has project management experience in the United States, Canada, Europe, Russia, Latin America, South Africa, Asia Pacific and Australia. Darcy is also experienced in managing all aspects of Phase I-IV clinical trials, including study design input, organizing DSMB, oversight of final study report (CSR) deliverable, IND and NDA submissions. Darcy has vendor management experience with Phase I units, central laboratories, PK/PD analytical labs, drug warehouses, recruitment vendors, meeting planners and EDC/IVR providers.
Director, Business Development
Dominic has more than 12 years of experience in the clinical research industry creating and supporting productive business relationships with CRO resources. His experience includes Phase I-IV and post-approval research involving numerous therapeutic areas and clinical operations services.
Contact our team if you plan to be in attendance at ASCO’s Annual Meeting or if you would like to learn more about our experience with oncology clinical trials. You can also download our free oncology eBooks and webcasts to learn more from our experts about topics such as immune checkpoint inhibitors and encouraging success in immuno-oncology clinical trials.